Eicosapentaenoic acid in the treatment of pediatric atopic dermatitis
Phase 3
- Conditions
- Atopic dermatitis.Other atopic dermatitis
- Registration Number
- IRCT20170608034390N2
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Pediatric patients with atopic dermatitis aged 6 months to 13 years
Exclusion Criteria
Age greater than 13 years
Extent of skin involvement less than 2% or more than 30% of the body surface
Other skin problems other than atopic dermatitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of eczema. Timepoint: Measuring the severity of eczema at the beginning of the study (before the intervention) and 2 and 4 days after starting the drug. Method of measurement: Based on a SCORing Atopic Dermatitis (SCORAD) Calculator.
- Secondary Outcome Measures
Name Time Method